Loading...

Baxter International Inc.

BTL.DEXETRA
Healthcare
Medical - Instruments & Supplies
58.80
0.00(0.00%)
German Market opens in 12h 50m

Baxter International Inc. Fundamental Analysis

Baxter International Inc. (BTL.DE) shows weak financial fundamentals with a PE ratio of -54.11, profit margin of -6.10%, and ROE of -8.45%. The company generates $10.5B in annual revenue with weak year-over-year growth of -69.53%.

Key Strengths

PEG Ratio0.11

Areas of Concern

ROE-8.45%
Operating Margin-1.05%
We analyze BTL.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -73.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-73.4/100

We analyze BTL.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

BTL.DE struggles to generate sufficient returns from assets.

ROA > 10%
-2.52%

Valuation Score

Excellent

BTL.DE trades at attractive valuation levels.

PE < 25
-54.11
PEG Ratio < 2
0.11

Growth Score

Weak

BTL.DE faces weak or negative growth trends.

Revenue Growth > 5%
-69.53%
EPS Growth > 10%
-1.12%

Financial Health Score

Moderate

BTL.DE shows balanced financial health with some risks.

Debt/Equity < 1
1.93
Current Ratio > 1
1.36

Profitability Score

Weak

BTL.DE struggles to sustain strong margins.

ROE > 15%
-844.72%
Net Margin ≥ 15%
-6.10%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BTL.DE Expensive or Cheap?

P/E Ratio

BTL.DE trades at -54.11 times earnings. This suggests potential undervaluation.

-54.11

PEG Ratio

When adjusting for growth, BTL.DE's PEG of 0.11 indicates potential undervaluation.

0.11

Price to Book

The market values Baxter International Inc. at 5.04 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.04

EV/EBITDA

Enterprise value stands at 20.60 times EBITDA. This signals the market has high growth expectations.

20.60

How Well Does BTL.DE Make Money?

Net Profit Margin

For every $100 in sales, Baxter International Inc. keeps $-6.10 as profit after all expenses.

-6.10%

Operating Margin

Core operations generate -1.05 in profit for every $100 in revenue, before interest and taxes.

-1.05%

ROE

Management delivers $-8.45 in profit for every $100 of shareholder equity.

-8.45%

ROA

Baxter International Inc. generates $-2.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Baxter International Inc. generates limited operating cash flow of $1.01B, signaling weaker underlying cash strength.

$1.01B

Free Cash Flow

Baxter International Inc. produces free cash flow of $552.00M, offering steady but limited capital for shareholder returns and expansion.

$552.00M

FCF Per Share

Each share generates $1.10 in free cash annually.

$1.10

FCF Yield

BTL.DE converts 1.61% of its market value into free cash.

1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-54.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.26

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.93

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.36

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How BTL.DE Stacks Against Its Sector Peers

MetricBTL.DE ValueSector AveragePerformance
P/E Ratio-54.1128.66 Better (Cheaper)
ROE-8.45%671.00% Weak
Net Margin-6.10%-44168.00% (disorted) Weak
Debt/Equity1.930.33 Weak (High Leverage)
Current Ratio1.364.49 Neutral
ROA-2.52%-17052.00% (disorted) Weak

BTL.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Baxter International Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-60.36%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-131.11%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-51.66%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ